403 related articles for article (PubMed ID: 30111561)
1. Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.
Lindquist ME; Zeng X; Altamura LA; Daye SP; Delp KL; Blancett C; Coffin KM; Koehler JW; Coyne S; Shoemaker CJ; Garrison AR; Golden JW
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111561
[TBL] [Abstract][Full Text] [Related]
2. Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.
Hawman DW; Meade-White K; Haddock E; Habib R; Scott D; Thomas T; Rosenke R; Feldmann H
J Virol; 2019 Sep; 93(18):. PubMed ID: 31292241
[TBL] [Abstract][Full Text] [Related]
3. Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy.
Zivcec M; Safronetz D; Scott D; Robertson S; Ebihara H; Feldmann H
J Infect Dis; 2013 Jun; 207(12):1909-21. PubMed ID: 23417661
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
[TBL] [Abstract][Full Text] [Related]
5. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
J Virol; 2017 May; 91(10):. PubMed ID: 28250124
[TBL] [Abstract][Full Text] [Related]
6. Nucleoside-Modified mRNA Vaccines Protect IFNAR
Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
[TBL] [Abstract][Full Text] [Related]
7. Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice.
Bereczky S; Lindegren G; Karlberg H; Akerström S; Klingström J; Mirazimi A
J Gen Virol; 2010 Jun; 91(Pt 6):1473-7. PubMed ID: 20164263
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model.
Bente DA; Alimonti JB; Shieh WJ; Camus G; Ströher U; Zaki S; Jones SM
J Virol; 2010 Nov; 84(21):11089-100. PubMed ID: 20739514
[TBL] [Abstract][Full Text] [Related]
9. Crimean-Congo hemorrhagic fever virus-infected hepatocytes induce ER-stress and apoptosis crosstalk.
Rodrigues R; Paranhos-Baccalà G; Vernet G; Peyrefitte CN
PLoS One; 2012; 7(1):e29712. PubMed ID: 22238639
[TBL] [Abstract][Full Text] [Related]
10. Hazara virus infection is lethal for adult type I interferon receptor-knockout mice and may act as a surrogate for infection with the human-pathogenic Crimean-Congo hemorrhagic fever virus.
Dowall SD; Findlay-Wilson S; Rayner E; Pearson G; Pickersgill J; Rule A; Merredew N; Smith H; Chamberlain J; Hewson R
J Gen Virol; 2012 Mar; 93(Pt 3):560-564. PubMed ID: 22090213
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Crimean-Congo Hemorrhagic Fever Virus and Aigai Virus in Life Cycle Modeling Systems Reveals a Difference in L Protein Activity.
Pickin MJ; Devignot S; Weber F; Groschup MH
J Virol; 2022 Jul; 96(13):e0059922. PubMed ID: 35695578
[TBL] [Abstract][Full Text] [Related]
12. The host inflammatory response contributes to disease severity in Crimean-Congo hemorrhagic fever virus infected mice.
Golden JW; Zeng X; Cline CR; Smith JM; Daye SP; Carey BD; Blancett CD; Shoemaker CJ; Liu J; Fitzpatrick CJ; Stefan CP; Garrison AR
PLoS Pathog; 2022 May; 18(5):e1010485. PubMed ID: 35587473
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte pathway alterations in response to in vitro Crimean Congo hemorrhagic fever virus infection.
Fraisier C; Rodrigues R; Vu Hai V; Belghazi M; Bourdon S; Paranhos-Baccala G; Camoin L; Almeras L; Peyrefitte CN
Virus Res; 2014 Jan; 179():187-203. PubMed ID: 24184319
[TBL] [Abstract][Full Text] [Related]
14. Stable Occupancy of the Crimean-Congo Hemorrhagic Fever Virus-Encoded Deubiquitinase Blocks Viral Infection.
Scholte FEM; Hua BL; Spengler JR; Dzimianski JV; Coleman-McCray JD; Welch SR; McMullan LK; Nichol ST; Pegan SD; Spiropoulou CF; Bergeron É
mBio; 2019 Jul; 10(4):. PubMed ID: 31337717
[TBL] [Abstract][Full Text] [Related]
15. ISG15 overexpression compensates the defect of Crimean-Congo hemorrhagic fever virus polymerase bearing a protease-inactive ovarian tumor domain.
Devignot S; Kromer T; Mirazimi A; Weber F
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008610. PubMed ID: 32931521
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in understanding Crimean-Congo hemorrhagic fever virus.
Hawman DW; Feldmann H
F1000Res; 2018; 7():. PubMed ID: 30416710
[TBL] [Abstract][Full Text] [Related]
17. Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus.
Hawman DW; Meade-White K; Leventhal S; Feldmann F; Okumura A; Smith B; Scott D; Feldmann H
Elife; 2021 Jan; 10():. PubMed ID: 33416494
[TBL] [Abstract][Full Text] [Related]
18. Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease.
Garrison AR; Smith DR; Golden JW
Viruses; 2019 Jun; 11(7):. PubMed ID: 31261754
[TBL] [Abstract][Full Text] [Related]
19. Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target.
Neogi U; Elaldi N; Appelberg S; Ambikan A; Kennedy E; Dowall S; Bagci BK; Gupta S; Rodriguez JE; Svensson-Akusjärvi S; Monteil V; Vegvari A; Benfeitas R; Banerjea A; Weber F; Hewson R; Mirazimi A
Elife; 2022 Apr; 11():. PubMed ID: 35437144
[TBL] [Abstract][Full Text] [Related]
20. RIG-I Mediates an Antiviral Response to Crimean-Congo Hemorrhagic Fever Virus.
Spengler JR; Patel JR; Chakrabarti AK; Zivcec M; García-Sastre A; Spiropoulou CF; Bergeron É
J Virol; 2015 Oct; 89(20):10219-29. PubMed ID: 26223644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
